Patients should always seek the advice of a doctor or pharmacist in case of adverse events.
If you wish to report an adverse event to ELC Group s.r.o., please find the contact information below:
To contact us about any other issue please call:
Pacienti by meli vždy požádat o radu svého lékare nebo lékárníka v prípade výskytu nežádoucích príhod.
Pokud chcete nahlásit nežádoucí príhodu spolecnosti ELC Group s r.o., prosím využijte kontaktních údaju níže:
Pro záležitosti, které se netýkaji farmakovigilance, kontaktujte prosím recepci:
+420 22 491 0000 nebo naše další pobočky.
On Tuesday 29th June, 2021, at 11:00 CEST (Central European Summer Time, UTC+ 2), ELC will be hosting a webinar providing an overview of Pharmacovigilance Requirements in US & EU .
The presenters will be Dr. Devang Patel, General Manager for Pharmacovigilance and Mr. Riaz Ali Khan, Business Development from ELC Group.
We are going to take you through the following topics:
1. PV Requirements in US & EU
2. Difference between PV requirements in US & EU
3. Setting up a Single System for PV in US & EU
4. Challenges & Approaches
5. Inspection Findings
6. Questions & Answers
Please note that the number of participants is limited.
To register, click here
